A common cause of graft failure is active and persistent antibody-mediated rejection, or AMR. It is not clear what the condition's prognostic indicators are. Our objective was to determine the demographic, histological, and clinical characteristics of AMR transplant recipients, as well as their effects on graft survival and options for antirejection therapy.
HTML PDFShare this article
Transplantation Technologies & Research received 223 citations as per Google Scholar report
